Skip to main content
. 2017 May 26;8(32):53168–53179. doi: 10.18632/oncotarget.18230

Figure 6. Schematic diagram of the working hypothesis.

Figure 6

BCG induces ERK phosphorylation via TLR 2, leading to c-Jun- and p65-dependent transcription of HBD2, HBD3, and CAMP. Pharmacological inhibition of ERK phosphorylation and/or genetic ablation of TLR2 enhance the anti-proliferative effects of BCG on bladder cancer cells.